AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol. The new ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

† Department of Biochemistry and Molecular Biology, and ‡ Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania 17033, United States § Department of ...